A non-invasive oral rinse assay predicts bone marrow engraftment and 6months prognosis following allogeneic hematopoietic stem cell transplantation

Journal of Oral Pathology and Medicine

Volumn 41, Issue 2, 2012, Pages 165-170

  Forster, Carol ^a   Aboodi, Guy ^a   Lipton, Jeff ^b   Glogauer, Michael ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Hematopoietic stem cell transplantation; Neutrophil; Oral rinse

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; IMATINIB; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASSAY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; ENGRAFTMENT; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; NON INVASIVE PROCEDURE; NONHODGKIN LYMPHOMA; NONMYELOABLATIVE CONDITIONING; ORAL RINSE ASSAY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROLYMPHOCYTIC LEUKEMIA; REMISSION; SCORING SYSTEM; STOMATITIS; TREATMENT FAILURE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; BONE MARROW; CYTODIAGNOSIS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LEUKOCYTE COUNT; LYMPHOMA; MOUTH MUCOSA; MOUTHWASHES; MYELODYSPLASTIC SYNDROMES; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PROGNOSIS; REMISSION INDUCTION; STOMATITIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84856469631     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01076.x     Document Type: Article

References (12)

1. Pavletic SZ, Kumar S, Mohty M, et al. NCI First international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the epidemiology and natural history of relapse following allogeneic celltransplantation. Biol Blood Marrow Transplant 2010; 16: 871-90.
2. Goldman JM, Horowitz MM. The international bone marrow transplant registry. Int J Hematol 2002; 76: 393-7.
3. 9/l neutrophils on 3 consecutive days to define myeloid recovery. Bone Marrow Transplant 2002; 30: 749-52.
4. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-22.
5. Zimmerli W, Zarth A, Gratwohl A, Speck B. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood 1991; 77: 393-9.
6. Raeste AM, Tapanila T, Tupakka R. Leukocyte migration into the healthy dentulous mouth. A study in children, adolescents and adults. J Periodontal Res 1977; 12: 444-9.
7. Cheretakis C, Dror Y, Glogauer M. A noninvasive oral rinse assay to monitor engraftment, neutrophil tissue delivery and susceptibility to infection following HSCT in pediatric patients. Bone Marrow Transplant 2005; 36: 227-32.
8. Cheretakis C, Leung R, Sun CX, Dror Y, Glogauer M. Timing of neutrophil tissue repopulation predicts restoration of innate immune protection in a murine bone marrow transplantation model. Blood 2006; 108: 2821-6.
9. Akpek G, Knight RD, Wright DG. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy. Am J Hematol 2003; 72: 13-9.
10. Smith DL, Rommel F. A rapid micro method for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitro. J Immunol Methods 1977; 17: 241-7.
11. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999; 85: 2103-3.
12. Shook D, Coustan-Smith E, Ribeiro RC, Rubnitz JE, Campana D. Minimal residual disease quantitation in acute myeloid leukemia. Clin Lymphoma Myeloma 2009; 9: S281-5.